# Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors

> **NCT04365023** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 168 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **DRUG:** platinum chemotherapy

## Key facts

- **NCT ID:** NCT04365023
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-02
- **Primary completion:** 2023-05-25
- **Final completion:** 2023-05-25
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2026-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04365023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04365023, "Cohort of Well-differentiated Grade 3 Neuroendocrine Digestive Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04365023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*